Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Small-molecule ligands that bind the RET receptor activate neuroprotective signals independent of but modulated by co-receptor GFRα1

Sean Jmaeff, Yulia Sidorova, Hayley Lippiatt, Pablo F. Barcelona, Hinyu Nedev, Lucia M. Saragovi, Mark A. Hancock, Mart Saarma and H. Uri Saragovi
Molecular Pharmacology May 3, 2020, mol.119.118950; DOI: https://doi.org/10.1124/mol.119.118950
Sean Jmaeff
1 Mcgill University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yulia Sidorova
2 University of Helsinki;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hayley Lippiatt
3 Lady Davis Institute;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pablo F. Barcelona
3 Lady Davis Institute;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hinyu Nedev
3 Lady Davis Institute;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lucia M. Saragovi
3 Lady Davis Institute;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark A. Hancock
1 Mcgill University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mart Saarma
2 University of Helsinki;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Uri Saragovi
4 McGill University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Abstract

Glial cell line-Derived Neurotrophic Factor (GDNF) binds the GFRα1 receptor, and the GDNF-GFRα1 complex binds to and activates the transmembrane RET tyrosine kinase to signal through intracellular Akt/Erk pathways. To dissect the GDNF-GFRα1-RET signaling complex, agents that bind and activate RET directly and independently of GFRα1 expression are valuable tools. In a focused naphthalenesulfonic acid library from the NCI database, we identified small molecules that are genuine ligands binding to the RET extracellular domain. These ligands activate RET tyrosine kinase and afford trophic signals irrespective of GFRα1 co-expression. However, RET activation by these ligands is constrained by GFRα1, likely via an allosteric mechanism that can be overcome by increasing RET ligand concentration. In a mouse model of retinitis pigmentosa, monotherapy with a small molecule RET agonist activates survival signals and reduces neuronal death significantly better than GDNF, suggesting therapeutic potential.

SIGNIFICANCE STATEMENT A genuine ligand of RET receptor ectodomain was identified, which acts as an agonist. Agonism is selective for cells expressing RET. The RET binding and the agonistic activities are independent of a co-receptor GFRα which is required by the natural growth factor GDNF. The lead agent protects neurons from death, and in vivo it is effective under conditions where the natural growth factor GDNF is ineffective. This work validates RET receptor as a druggable therapeutic target, and provides for potential leads to evaluate in neurodegenerative states. In addition, we report the potential problems that arise when screening chemical libraries, as a matter of education to the readership.

  • Drug development
  • Drug discovery
  • Neurodegeneration
  • Neuroprotection
  • Neurotrophic factors
  • Receptor tyrosine kinases (RTKs)
  • Retina
  • Signal transduction networks
  • The American Society for Pharmacology and Experimental Therapeutics
Next
Back to top

In this issue

Molecular Pharmacology: 103 (2)
Molecular Pharmacology
Vol. 103, Issue 2
1 Feb 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Small-molecule ligands that bind the RET receptor activate neuroprotective signals independent of but modulated by co-receptor GFRα1
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Small-molecule ligands that bind the RET receptor activate neuroprotective signals independent of but modulated by co-receptor GFRα1

Sean Jmaeff, Yulia Sidorova, Hayley Lippiatt, Pablo F. Barcelona, Hinyu Nedev, Lucia M. Saragovi, Mark A. Hancock, Mart Saarma and H. Uri Saragovi
Molecular Pharmacology May 3, 2020, mol.119.118950; DOI: https://doi.org/10.1124/mol.119.118950

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Small-molecule ligands that bind the RET receptor activate neuroprotective signals independent of but modulated by co-receptor GFRα1

Sean Jmaeff, Yulia Sidorova, Hayley Lippiatt, Pablo F. Barcelona, Hinyu Nedev, Lucia M. Saragovi, Mark A. Hancock, Mart Saarma and H. Uri Saragovi
Molecular Pharmacology May 3, 2020, mol.119.118950; DOI: https://doi.org/10.1124/mol.119.118950
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The binding site for KCI807 in the androgen receptor
  • Fatty acid amide hydrolase in cisplatin nephrotoxicity
  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics